Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort

Author:

Lázari Carolina dos Santos,Ramundo Mariana SeveroORCID,ten-Caten Felipe,Bressan Clarisse S.,de Filippis Ana Maria Bispo,Manuli Erika Regina,de Moraes Isabella,Pereira Geovana Maria,Côrtes Marina Farrel,Candido Darlan da Silva,Gerber Alexandra L.,Guimarães Ana Paula,Faria Nuno Rodrigues,Nakaya Helder I.,Vasconcelos Ana Tereza R.,Brasil Patrícia,Paranhos-Baccalà Gláucia,Sabino Ester Cerdeira

Abstract

Background Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25–40% individuals and, though most of them are characterized by long-lasting arthralgia alone, many of them exhibit persistent or recurrent inflammatory signs that define post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD). We aimed to identify early clinical markers of evolution to pCHIKV-CIJD during acute and post-acute phases. Methodology/Principal findings We studied a prospective cohort of CHIKF-confirmed volunteers with longitudinal clinical data collection from symptoms onset up to 90 days, including a 21-day visit (D21). Of 169 patients with CHIKF, 86 (50.9%) completed the follow-up, from whom 39 met clinical criteria for pCHIKV-CIJD (45.3%). The relative risk of chronification was higher in women compared to men (RR = 1.52; 95% CI = 1.15–1.99; FDR = 0.03). None of the symptoms or signs presented at D0 behaved as an early predictor of pCHIKV-CIJD, while being symptomatic at D21 was a risk factor for chronification (RR = 1.31; 95% CI = 1.09–1.55; FDR = 0.03). Significance was also observed for joint pain (RR = 1.35; 95% CI = 1.12–1.61; FDR = 0.02), reported edema (RR = 3.61; 95% CI = 1.44–9.06; FDR = 0.03), reported hand and/or feet small joints edema (RR = 4.22; 95% CI = 1.51–11.78; FDR = 0.02), and peri-articular edema observed during physical examination (RR = 2.89; 95% CI = 1.58–5.28; FDR = 0.002). Furthermore, patients with no findings in physical examination at D21 were at lower risk of chronic evolution (RR = 0.41, 95% CI = 0.24–0.70, FDR = 0.01). Twenty-nine pCHIKV-CIJD patients had abnormal articular ultrasonography (90.6% of the examined). The most common findings were synovitis (65.5%) and joint effusion (58.6%). Conclusion This cohort has provided important insights into the prognostic evaluation of CHIKF. Symptomatic sub-acute disease is a relevant predictor of evolution to chronic arthritis with synovitis, drawing attention to joint pain, edema, multiple articular involvement including small hand and feet joints as risk factors for chronification beyond three months, especially in women. Future studies are needed to accomplish the identification of accurate and early biomarkers of poor clinical prognosis, which would allow better understanding of the disease’s evolution and improve patients’ management, modifying CHIKF burden on global public health.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo-Universidade de São Paulo-bioMérieux S.A. – PITE2 ARBOBIOS

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Faculdade de Medicina da Universidade de São Paulo

Fundação de Amparo à Pesquisa do Estado de São Paulo

Wellcome Trust and Royal Society Sir Henry Dale Fellowship

Medical Research Council-Fundação de Amparo à Pesquisa do Estado de São Paulo - CADDE partnership award

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference47 articles.

1. Arrival of chikungunya virus in the new world: prospects for spread and impact on public health;SC Weaver;PLoS Negl Trop Dis,2014

2. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review;A Lo Presti;Infect Genet Evol,2016

3. The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines;AA Bettis;PLoS Negl Trop Dis,2022

4. Pan–American Health Organization. PLISA Health Information Platform for the Americas. 2022 [cited 13 May 2022]. Available: https://www3.paho.org/data/index.php/en/mnu–topics/chikv–en/550–chikv–weekly–en.html

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3